Humacyte, Inc.
HUMA
$0.58
-$0.02-2.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -17.98% | 6.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -17.98% | 6.00% | |||
| Cost of Revenue | -7.30% | -11.77% | |||
| Gross Profit | 7.04% | 12.12% | |||
| SG&A Expenses | 2.52% | 2.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.62% | -8.22% | |||
| Operating Income | 4.39% | 8.43% | |||
| Income Before Tax | -108.88% | 28.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -108.88% | 28.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -108.88% | 28.97% | |||
| EBIT | 4.39% | 8.43% | |||
| EBITDA | 4.67% | 8.96% | |||
| EPS Basic | -76.43% | 32.91% | |||
| Normalized Basic EPS | -33.04% | -59.07% | |||
| EPS Diluted | -77.78% | 32.23% | |||
| Normalized Diluted EPS | -33.04% | -59.07% | |||
| Average Basic Shares Outstanding | 18.37% | 5.92% | |||
| Average Diluted Shares Outstanding | 18.37% | 5.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||